Author:
Li Teng,Xing Yi,Liu Shu-cheng,Han Xiao-min,Li Wen-cheng,Chen Min
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Biomedical Engineering,Biomaterials,Biochemistry
Reference36 articles.
1. MRC Working Party on Urological Cancer. The effect of intravesical thiotepa on the recurrence rate of newly diagnosed superficial bladder cancer. An MRC study. Br J Urol, 1985,57(6):680–685
2. Thrasher JB, Crawford ED. Complications of intravesical chemotherapy. Urol Clin North Am, 1992,19(3):529–539
3. Medical Research Council Working Party on Urological Cancer, Subgroup on Superficial Bladder Cancer. The effect of intravesical thiotepa on tumour recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trial. Br J Urol, 1994,73(6):632–638
4. Shelley MD, G Jones, A Cleves, et al. Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review. BJU Int, 2012,109(4): 496–505
5. Jones G, Cleves A, Wilt TJ, et al. Intravesical gemcitabine for non-muscle invasive bladder cancer. Cochrane Database Syst Rev, 2012, 1:CD009294
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献